Immediate Impact
56 standout
Citing Papers
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
2023 Standout
Outcomes after Critical Illness
2023 Standout
Works of Olav Hevrøy being referenced
Family members’ experiences of “wait and see” as a communication strategy in end-of-life decisions
2011
Cardiac Effects of Secretin; an Approach to its Mechanisms of Action as Shown by Beta-Adrenergic Blockade and Measurement of Left Ventricular Dimensions in Dogs
1989
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Olav Hevrøy | 72 | 41 | 63 | 117 | 103 | 22 | 359 | |
| Hildy Schell‐Chaple | 37 | 16 | 47 | 77 | 37 | 21 | 314 | |
| Anna Krupp | 24 | 28 | 51 | 93 | 35 | 28 | 366 | |
| Sarah Vollam | 76 | 105 | 42 | 31 | 97 | 30 | 411 | |
| James M. Feeney | 109 | 8 | 37 | 53 | 82 | 29 | 404 | |
| Andrew Casamento | 29 | 8 | 37 | 78 | 143 | 17 | 316 | |
| L. Zapata | 81 | 43 | 107 | 32 | 89 | 28 | 375 | |
| Dorothy M. Beke | 32 | 64 | 31 | 127 | 77 | 15 | 356 | |
| Paweł Andruszkiewicz | 78 | 20 | 106 | 60 | 53 | 39 | 375 | |
| Robert L. Jayes | 126 | 6 | 29 | 140 | 86 | 15 | 351 | |
| Sara Gregg | 50 | 13 | 34 | 45 | 82 | 18 | 371 |
All Works
Loading papers...